{"id":712,"date":"2019-07-18T08:28:02","date_gmt":"2019-07-18T12:28:02","guid":{"rendered":"https:\/\/lab.research.sickkids.ca\/parekh\/?page_id=712"},"modified":"2019-08-21T07:29:28","modified_gmt":"2019-08-21T11:29:28","slug":"pace","status":"publish","type":"page","link":"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/","title":{"rendered":"PACE"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_custom_heading text=&#8221;Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease&#8221; font_container=&#8221;tag:h2|font_size:20|text_align:left|line_height:1&#8243; google_fonts=&#8221;font_family:Arimo%3Aregular%2Citalic%2C700%2C700italic|font_style:700%20bold%20regular%3A700%3Anormal&#8221;][vc_column_text]<\/p>\n<hr \/>\n<p>[\/vc_column_text][vc_column_text]<strong>Overview<\/strong>: PACE was a prospective cohort study that enrolled 568 persons with end-stage renal disease (ESRD) initiating hemodialysis. Participants were recruited in Baltimore and the surrounding area (U.S.) from November 2008 to August 2012. In addition to complete baseline evaluations, participants were actively followed for up to four\u00a0years during which time data from clinic and phone questionnaires, study visits, cardiovascular assessments, and biological specimens were collected. Recently, data from these participants were linked with the United States Renal Data System to obtain long-term outcomes.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Objectives<\/strong>: The primary objectives of this study were to identify the rate of sudden cardiac death among adults initiating hemodialysis and to determine risk factors associated with arrhythmias and sudden cardiac death.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Progress<\/strong>: Data collection was completed in 2016 and linkage with the United States Renal Data System was established in 2018. To date, the study has identified a number of risk factors for sudden cardiac death including spatial QRS-T angle and abdominal obesity.[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/3&#8243;][vc_single_image image=&#8221;275&#8243; img_size=&#8221;200&#215;200&#8243; alignment=&#8221;center&#8221; style=&#8221;vc_box_shadow&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_custom_heading text=&#8221;Co-Investigators&#8221; font_container=&#8221;tag:h2|font_size:20|text_align:left|color:%23000000|line_height:1&#8243; google_fonts=&#8221;font_family:Arimo%3Aregular%2Citalic%2C700%2C700italic|font_style:700%20bold%20regular%3A700%3Anormal&#8221;][vc_empty_space][vc_separator][vc_column_text]<strong>Dr. Bernard G. Jaar<\/strong> is an assistant professor in the School of Medicine and the Department of Epidemiology at Johns Hopkins University. His research interests include outcome studies of peripheral arterial disease among end stage kidney disease (ESKD) patients and morbidity and mortality of individuals with ESKD by dialysis modality.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Dr. Stephen M. Sozio<\/strong> is an associate professor in the School of Medicine and the Associate Director of the Nephrology Fellowship Program at Johns Hopkins University. His research interests include chronic kidney disease epidemiology, arterial stiffness and calcification as risk factors for stroke and cognitive impairment in patients with kidney disease, and medical education.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Dr. Michelle M. Estrella<\/strong> is an associate professor in the School of Medicine at the University of California, San Francisco. Her research interests include developing strategies to reduce the risk of chronic kidney disease development and progression among HIV-infected individuals and minority groups.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Dr. Larisa G. Tereshchenko<\/strong> is an associate professor in the Division of Cardiovascular Medicine in the School of Medicine at the Oregon Health and Science University. Her research interests include novel methods of ECG analyses and development of ECG risk scores for sudden cardiac death.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Dr. Jose Monroy-Trujillo<\/strong> is an assistant professor in the School of Medicine at Johns Hopkins University. His area of clinical expertise is nephrology.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=&#8221;50px&#8221;][vc_custom_heading text=&#8221;Collaborators&#8221; font_container=&#8221;tag:h2|font_size:20|text_align:left|color:%23000000|line_height:1&#8243; google_fonts=&#8221;font_family:Arimo%3Aregular%2Citalic%2C700%2C700italic|font_style:700%20bold%20regular%3A700%3Anormal&#8221;][vc_separator][vc_column_text]<strong>Dr. Wei Chen<\/strong> is an assistant professor in the Department of Medicine at the Albert Einstein College of Medicine. Her research interests include disorders of metabolism and biomarker development for vascular calcification in chronic kidney disease.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Dr. Teresa Chen<\/strong> is an assistant professor in the School of Medicine at Johns Hopkins University. Her research interests include chronic kidney disease epidemiology and genetic risk factors for chronic kidney disease and outcomes.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Dr. Mark Mitsnefes<\/strong> is a professor in the Department of Pediatrics at the University of Cincinnati and the Director of the Clinical and Translational Research Center at Cincinnati Children\u2019s Hospital. His research interests include cardiovascular complications of chronic kidney disease and clinical trials in hypertension.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][vc_custom_heading text=&#8221;Select PACE Publications:&#8221; font_container=&#8221;tag:h2|font_size:20|text_align:center|color:%23ffffff|line_height:1&#8243; google_fonts=&#8221;font_family:Arimo%3Aregular%2Citalic%2C700%2C700italic|font_style:700%20bold%20regular%3A700%3Anormal&#8221; css=&#8221;.vc_custom_1564414979839{padding-top: 10px !important;padding-bottom: 10px !important;background-color: #000000 !important;}&#8221;][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/6&#8243;][vc_column_text]<\/p>\n<p style=\"text-align: center\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6551514\/pdf\/main.pdf\" target=\"_blank\" rel=\"noopener\">Diabetes Mellitus Modifies the Associations of Serum Magnesium Concentration With\u00a0Arterial Calcification and Stiffness in\u00a0Incident Hemodialysis Patients.<\/a><\/p>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/6&#8243;][vc_column_text]<\/p>\n<p style=\"text-align: center\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6474045\/pdf\/12882_2019_Article_1282.pdf\" target=\"_blank\" rel=\"noopener\">Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.<\/a><\/p>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/6&#8243;][vc_column_text]<\/p>\n<p style=\"text-align: center\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30428465\" target=\"_blank\" rel=\"noopener\">Association of Abdominal Adiposity with Cardiovascular Mortality in Incident Hemodialysis.<\/a><\/p>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/6&#8243;][vc_column_text]<\/p>\n<p style=\"text-align: center\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=30143433\" target=\"_blank\" rel=\"noopener\">Plasma glucosylceramides and cardiovascular risk in incident hemodialysis patients.<\/a><\/p>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/6&#8243;][vc_column_text]<\/p>\n<p style=\"text-align: center\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6365769\/pdf\/gfy124.pdf\" target=\"_blank\" rel=\"noopener\">Frailty, body composition and the risk of mortality in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease study.<\/a><\/p>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/6&#8243;][vc_column_text]<\/p>\n<p style=\"text-align: center\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5084888\/\" target=\"_blank\" rel=\"noopener\">Electrophysiologic Substrate and Risk of Mortality in Incident Hemodialysis.<\/a><\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/6&#8243;][\/vc_column][vc_column width=&#8221;1\/6&#8243;][\/vc_column][vc_column width=&#8221;1\/6&#8243;][vc_column_text]<\/p>\n<p style=\"text-align: center\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4528691\/pdf\/12882_2015_Article_131.pdf\" target=\"_blank\" rel=\"noopener\">Cross-sectional association of volume, blood pressures, and aortic stiffness with left ventricular mass in incident hemodialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.<\/a><\/p>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/6&#8243;][vc_column_text]<\/p>\n<p style=\"text-align: center\"><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4434806\/pdf\/12882_2015_Article_50.pdf\" target=\"_blank\" rel=\"noopener\">Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study.<\/a><\/p>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/6&#8243;][\/vc_column][vc_column width=&#8221;1\/6&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_custom_heading text=&#8221;Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease&#8221; font_container=&#8221;tag:h2|font_size:20|text_align:left|line_height:1&#8243; google_fonts=&#8221;font_family:Arimo%3Aregular%2Citalic%2C700%2C700italic|font_style:700%20bold%20regular%3A700%3Anormal&#8221;][vc_column_text] [\/vc_column_text][vc_column_text]Overview: PACE was a prospective cohort study that enrolled 568 persons with end-stage renal disease (ESRD) initiating hemodialysis. Participants were recruited in Baltimore and the surrounding area (U.S.) from November 2008 to August 2012. In addition to complete baseline evaluations,&hellip;<\/p>\n","protected":false},"author":82,"featured_media":0,"parent":14,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-712","page","type-page","status-publish","hentry","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.0 (Yoast SEO v27.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>PACE - The Parekh Lab<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PACE\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_custom_heading text=&#8221;Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease&#8221; font_container=&#8221;tag:h2|font_size:20|text_align:left|line_height:1&#8243; google_fonts=&#8221;font_family:Arimo%3Aregular%2Citalic%2C700%2C700italic|font_style:700%20bold%20regular%3A700%3Anormal&#8221;][vc_column_text] [\/vc_column_text][vc_column_text]Overview: PACE was a prospective cohort study that enrolled 568 persons with end-stage renal disease (ESRD) initiating hemodialysis. Participants were recruited in Baltimore and the surrounding area (U.S.) from November 2008 to August 2012. In addition to complete baseline evaluations,&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/\" \/>\n<meta property=\"og:site_name\" content=\"The Parekh Lab\" \/>\n<meta property=\"article:modified_time\" content=\"2019-08-21T11:29:28+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/\",\"url\":\"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/\",\"name\":\"PACE - The Parekh Lab\",\"isPartOf\":{\"@id\":\"https:\/\/lab.research.sickkids.ca\/parekh\/#website\"},\"datePublished\":\"2019-07-18T12:28:02+00:00\",\"dateModified\":\"2019-08-21T11:29:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/lab.research.sickkids.ca\/parekh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projects\",\"item\":\"https:\/\/lab.research.sickkids.ca\/parekh\/research\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"PACE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lab.research.sickkids.ca\/parekh\/#website\",\"url\":\"https:\/\/lab.research.sickkids.ca\/parekh\/\",\"name\":\"The Parekh Lab\",\"description\":\"Working to give children with kidney disease a brighter future.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lab.research.sickkids.ca\/parekh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"PACE - The Parekh Lab","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/","og_locale":"en_US","og_type":"article","og_title":"PACE","og_description":"[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_custom_heading text=&#8221;Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease&#8221; font_container=&#8221;tag:h2|font_size:20|text_align:left|line_height:1&#8243; google_fonts=&#8221;font_family:Arimo%3Aregular%2Citalic%2C700%2C700italic|font_style:700%20bold%20regular%3A700%3Anormal&#8221;][vc_column_text] [\/vc_column_text][vc_column_text]Overview: PACE was a prospective cohort study that enrolled 568 persons with end-stage renal disease (ESRD) initiating hemodialysis. Participants were recruited in Baltimore and the surrounding area (U.S.) from November 2008 to August 2012. In addition to complete baseline evaluations,&hellip;","og_url":"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/","og_site_name":"The Parekh Lab","article_modified_time":"2019-08-21T11:29:28+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/","url":"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/","name":"PACE - The Parekh Lab","isPartOf":{"@id":"https:\/\/lab.research.sickkids.ca\/parekh\/#website"},"datePublished":"2019-07-18T12:28:02+00:00","dateModified":"2019-08-21T11:29:28+00:00","breadcrumb":{"@id":"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/lab.research.sickkids.ca\/parekh\/research\/pace\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lab.research.sickkids.ca\/parekh\/"},{"@type":"ListItem","position":2,"name":"Projects","item":"https:\/\/lab.research.sickkids.ca\/parekh\/research\/"},{"@type":"ListItem","position":3,"name":"PACE"}]},{"@type":"WebSite","@id":"https:\/\/lab.research.sickkids.ca\/parekh\/#website","url":"https:\/\/lab.research.sickkids.ca\/parekh\/","name":"The Parekh Lab","description":"Working to give children with kidney disease a brighter future.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lab.research.sickkids.ca\/parekh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/lab.research.sickkids.ca\/parekh\/wp-json\/wp\/v2\/pages\/712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lab.research.sickkids.ca\/parekh\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lab.research.sickkids.ca\/parekh\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lab.research.sickkids.ca\/parekh\/wp-json\/wp\/v2\/users\/82"}],"replies":[{"embeddable":true,"href":"https:\/\/lab.research.sickkids.ca\/parekh\/wp-json\/wp\/v2\/comments?post=712"}],"version-history":[{"count":8,"href":"https:\/\/lab.research.sickkids.ca\/parekh\/wp-json\/wp\/v2\/pages\/712\/revisions"}],"predecessor-version":[{"id":806,"href":"https:\/\/lab.research.sickkids.ca\/parekh\/wp-json\/wp\/v2\/pages\/712\/revisions\/806"}],"up":[{"embeddable":true,"href":"https:\/\/lab.research.sickkids.ca\/parekh\/wp-json\/wp\/v2\/pages\/14"}],"wp:attachment":[{"href":"https:\/\/lab.research.sickkids.ca\/parekh\/wp-json\/wp\/v2\/media?parent=712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}